These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 21693322

  • 1. Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice.
    Chen C, Cao J, Zeng L, Li Y, Wang D, Xu K.
    Transplant Proc; 2011 Jun; 43(5):2041-8. PubMed ID: 21693322
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A subset of asialo GM1+ cells play a protective role in the occurrence of graft-versus-host disease in mice.
    De Ruysscher D, Sobis H, Vandeputte M, Waer M.
    J Immunol; 1991 Jun 15; 146(12):4065-70. PubMed ID: 1828259
    [Abstract] [Full Text] [Related]

  • 5. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
    Sang W, Zhou C, Cheng N, Li Z, Zeng L, Xu K.
    Immunol Lett; 2011 May 15; 136(2):194-202. PubMed ID: 21277900
    [Abstract] [Full Text] [Related]

  • 6. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M, Guinet E, Nouri-Shirazi M.
    Transpl Immunol; 2009 Dec 15; 22(1-2):82-92. PubMed ID: 19635560
    [Abstract] [Full Text] [Related]

  • 7. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells.
    Fukui J, Inaba M, Ueda Y, Miyake T, Hosaka N, Kwon AH, Sakaguchi Y, Tsuda M, Omae M, Kamiyama Y, Ikehara S.
    Stem Cells; 2007 Jun 15; 25(6):1595-601. PubMed ID: 17446564
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM, Eaton VL, Lerret NM, Correa LA, Decresce RP, García LF, Jaramillo A.
    Transpl Immunol; 2008 May 15; 19(2):127-35. PubMed ID: 18503888
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.
    Duramad O, Laysang A, Li J, Ishii Y, Namikawa R.
    Biol Blood Marrow Transplant; 2011 Aug 15; 17(8):1154-68. PubMed ID: 21145405
    [Abstract] [Full Text] [Related]

  • 11. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC, Song CW, Blazar BR, Vallera DA.
    J Immunol; 1985 Aug 15; 135(2):941-6. PubMed ID: 3891856
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 Aug 15; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
    Blazar BR, Taylor PA, Snover DC, Bluestone JA, Vallera DA.
    J Immunol; 1993 Jan 01; 150(1):265-77. PubMed ID: 8417127
    [Abstract] [Full Text] [Related]

  • 16. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A, Noble A.
    J Leukoc Biol; 2007 Nov 01; 82(5):1053-61. PubMed ID: 17684039
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y, Guo K, Chen Y, Song Z, Li J, Deng L.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug 01; 23(8):411-4. PubMed ID: 12411044
    [Abstract] [Full Text] [Related]

  • 20. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM, Gorechlad J, Larsen CP, Waller EK.
    Biol Blood Marrow Transplant; 2006 Dec 01; 12(12):1239-49. PubMed ID: 17162205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.